Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Lancet Oncol. 2023 Sep 8;24(10):1083–1093. doi: 10.1016/S1470-2045(23)00388-1

Table 4.

Invasive disease-free survival events

Event Conventional (n = 41) Hypofractionation (n = 41)
Recurrence1, n (%) 4 (9.8%) 3 (7.3%)
 Invasive IBTR 0 1 (2.4%)
 Regional 0 1 (2.4%)
 Distant 4 (9.8%) 3 (7.3%)
Contralateral invasive breast cancer 0 0
Second primary invasive cancer 0 0
Death without progression 0 1 (2.4%)
1

First recurrence events